Worse Breast Cancer Prognosis of BRCA1/BRCA2 Mutation Carriers: What's the Evidence? A Systematic Review with Meta-AnalysisAlexandra J. van den Broek, Flora E. van Leeuwen, Marjanka K. Schmidt et al.|PLoS ONE|2015Cited by 137
Impact of Age at Primary Breast Cancer on Contralateral Breast Cancer Risk in <i>BRCA1/2</i> Mutation CarriersAlexandra J. van den Broek, Marjanka K. Schmidt, M.L.G. Janssen‐Heijnen et al.|Journal of Clinical Oncology|2015Cited by 104
Breast Cancer Survival of BRCA1/BRCA2 Mutation Carriers in a Hospital-Based Cohort of Young WomenMarjanka K. Schmidt, Laura van ‘t Veer, Alexandra J. van den Broek et al.|JNCI Journal of the National Cancer Institute|2016Cited by 85
Accuracy of the online prognostication tools PREDICT and Adjuvant! for early-stage breast cancer patients younger than 50 yearsEllen G. Engelhardt, Marjanka K. Schmidt, Alexandra J. van den Broek et al.|European Journal of Cancer|2017Cited by 60
Prognostic Impact of Breast-Conserving Therapy Versus Mastectomy of BRCA1/2 Mutation Carriers Compared With Noncarriers in a Consecutive Series of Young Breast Cancer PatientsAlexandra J. van den Broek, Rob A.�E.�M. Tollenaar, Marjanka K. Schmidt et al.|Annals of Surgery|2018Cited by 58